U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07679750) titled 'rTMS Device for Improvement of Obsessive and Compulsive Behaviors' on June 24.

Brief Summary: The goal of this investigational study is to evaluate if the treatment using EXOMIND(BTL-699-2) device is able to improve severity of obsessive and compulsive symptoms in adults (aged 22 and older).

The main question it aims to answer is:

Does the treatment using EXOMIND (BTL-699-2) device is able safely and efficiently reduce the severity of obsessive and compulsive behaviors?

Participants will be asked to:

* Complete six treatment visits (twelve treatment sessions)

* Complete The Yale-Brown Obsessive-Compulsive Severity Scale Second E...